![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Astrazeneca Plc | LSE:AZN | London | Ordinary Share | GB0009895292 | ORD SHS $0.25 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-20.00 | -0.16% | 12,106.00 | 12,120.00 | 12,122.00 | 12,190.00 | 12,024.00 | 12,080.00 | 999,558 | 16:35:02 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 45.81B | 5.96B | 3.8415 | 31.55 | 187.98B |
RNS Number:7010U AstraZeneca PLC 28 January 2004 AstraZeneca Fourth Quarter and Full Year Results 2003 Tomorrow, Thursday, 29 January 2004, AstraZeneca will be releasing Fourth Quarter and Full Year results 2003 at 11:00gmt. The analyst presentation at 13:00gmt will be followed by a Q&A session which can be joined, live, via teleconference on the following numbers: UK: 0800 279 9640, for Europe: +44 (0)207 019 9504 and for the US: 866 850 2201 . These numbers, and details of the replay facility available through 09:00 Monday, 9 February 2004, are available on the Investor Relations part of the AstraZeneca website at www.astrazeneca.com. A live webcast of the presentation will also be available on this site. This information is provided by RNS The company news service from the London Stock Exchange END NORQKOKKOBKDDDB
1 Year Astrazeneca Chart |
1 Month Astrazeneca Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions